36501174|t|Update on Omega-3 Polyunsaturated Fatty Acids on Cardiovascular Health.
36501174|a|Twenty percent of deaths in the United States are secondary to cardiovascular diseases (CVD). In patients with hyperlipidemia and hypertriglyceridemia, studies have shown high atherosclerotic CVD (ASCVD) event rates despite the use of statins. Given the association of high triglyceride (TG) levels with elevated cholesterol and low levels of high-density lipoprotein cholesterol, the American Heart Association (AHA)/American College of Cardiology (ACC) cholesterol guidelines recommend using elevated TGs as a "risk-enhancing factor" for ASCVD and using omega 3 fatty acids (Omega3FAs) for patients with persistently elevated severe hypertriglyceridemia. Omega3FA, or fish oils (FOs), have been shown to reduce very high TG levels, hospitalizations, and CVD mortality in randomized controlled trials (RCTs). We have published the largest meta-analysis to date demonstrating significant effects on several CVD outcomes, especially fatal myocardial infarctions (MIs) and total MIs. Despite the most intensive research on Omega3FAs on CVD, their benefits have been demonstrated to cluster across multiple systems and pathologies, including autoimmune diseases, infectious diseases, chronic kidney disease, central nervous system diseases, and, most recently, the COVID-19 pandemic. A review and summary of the controversies surrounding Omega3FAs, some of the latest evidence-based findings, and the current and most updated recommendations on Omega3FAs are presented in this paper.
36501174	10	45	Omega-3 Polyunsaturated Fatty Acids	Chemical	MESH:D015525
36501174	90	96	deaths	Disease	MESH:D003643
36501174	135	158	cardiovascular diseases	Disease	MESH:D002318
36501174	160	163	CVD	Disease	MESH:D002318
36501174	169	177	patients	Species	9606
36501174	183	197	hyperlipidemia	Disease	MESH:D006949
36501174	202	222	hypertriglyceridemia	Disease	MESH:D015228
36501174	248	267	atherosclerotic CVD	Disease	MESH:D050197
36501174	269	274	ASCVD	Disease	MESH:D050197
36501174	346	358	triglyceride	Chemical	MESH:D014280
36501174	360	362	TG	Chemical	MESH:D014280
36501174	385	396	cholesterol	Chemical	MESH:D002784
36501174	527	538	cholesterol	Chemical	MESH:D002784
36501174	575	578	TGs	Chemical	MESH:C026285
36501174	612	617	ASCVD	Disease	MESH:D050197
36501174	628	647	omega 3 fatty acids	Chemical	MESH:D015525
36501174	649	658	Omega3FAs	Chemical	MESH:D015525
36501174	664	672	patients	Species	9606
36501174	707	727	hypertriglyceridemia	Disease	MESH:D015228
36501174	729	737	Omega3FA	Chemical	MESH:D015525
36501174	742	751	fish oils	Chemical	MESH:D005395
36501174	753	756	FOs	Chemical	MESH:D005395
36501174	795	797	TG	Chemical	MESH:D014280
36501174	828	831	CVD	Disease	MESH:D002318
36501174	979	982	CVD	Disease	MESH:D002318
36501174	1010	1032	myocardial infarctions	Disease	MESH:D009203
36501174	1034	1037	MIs	Disease	MESH:D009203
36501174	1049	1052	MIs	Disease	MESH:D009203
36501174	1093	1102	Omega3FAs	Chemical	MESH:D015525
36501174	1106	1109	CVD	Disease	MESH:D002318
36501174	1211	1230	autoimmune diseases	Disease	MESH:D001327
36501174	1232	1251	infectious diseases	Disease	MESH:D003141
36501174	1253	1275	chronic kidney disease	Disease	MESH:D051436
36501174	1277	1308	central nervous system diseases	Disease	MESH:D002493
36501174	1334	1342	COVID-19	Disease	MESH:D000086382
36501174	1407	1416	Omega3FAs	Chemical	MESH:D015525
36501174	1514	1523	Omega3FAs	Chemical	MESH:D015525
36501174	Negative_Correlation	MESH:D015525	MESH:D001327
36501174	Association	MESH:D015525	MESH:D000086382
36501174	Negative_Correlation	MESH:D015525	MESH:D051436
36501174	Negative_Correlation	MESH:D014280	MESH:D015525
36501174	Positive_Correlation	MESH:D015525	MESH:D002493
36501174	Negative_Correlation	MESH:D015525	MESH:D003141
36501174	Negative_Correlation	MESH:D005395	MESH:D002318
36501174	Negative_Correlation	MESH:D015525	MESH:D015228
36501174	Negative_Correlation	MESH:D005395	MESH:D014280
36501174	Positive_Correlation	MESH:C026285	MESH:D050197
36501174	Negative_Correlation	MESH:D015525	MESH:D002318

